Prevalence of Vitiligo and Associated Comorbidities in Korea
2
조회
0
다운로드
11
인용
0
참고문헌
키워드
초록
Purpose: Vitiligo prevalence and its associated comorbidities rate have been reportedvariably among different populations. We aimed to determine the prevalence of vitiligo in Korea along with the baseline rate of comorbidities and compared the risks to the general population using hospital visit information of the total population in Korea. Materials and Methods: We assessed demographic characteristics of vitiligopatients in Korean population from 2009 to 2011 in a nationwide data from Health Insurance Review Assessment Service. Patients who had at least one visit to Korea’s primary, secondary, or tertiary referral hospitals with International Classificationof Diseases, 10th Revision, Clinical Modification diagnosis code for vitiligo were identified. As a supplementary study, comorbidities associated with vitiligo were selected for further review to calculate relative risks compared to the general population. Results: The annual prevalence of vitiligo determined by hospital-visitingrate in Korea was 0.12% to 0.13% over a three year period. In sync with other previous epidemiological studies, there was bimodal distribution among the age groups and no difference between genders. Also, vitiligo in Korean population was associated with various autoimmune/non-autoimmune diseases such as thyroiditis, atopic dermatitis, and psoriasis. Conclusion: This study was by far the most comprehensivereview on prevalence of vitiligo using a data of total population in Korea. The prevalence is within a range of those reported in previous literatures, and increasedrisk of comorbidities such as thyroid diseases and psoriasis in vitiligo might aid clinicians in the initial work up of vitiligo patients and concurrent follow ups.
Abstract
Purpose: Vitiligo prevalence and its associated comorbidities rate have been reportedvariably among different populations. We aimed to determine the prevalence of vitiligo in Korea along with the baseline rate of comorbidities and compared the risks to the general population using hospital visit information of the total population in Korea. Materials and Methods: We assessed demographic characteristics of vitiligopatients in Korean population from 2009 to 2011 in a nationwide data from Health Insurance Review Assessment Service. Patients who had at least one visit to Korea’s primary, secondary, or tertiary referral hospitals with International Classificationof Diseases, 10th Revision, Clinical Modification diagnosis code for vitiligo were identified. As a supplementary study, comorbidities associated with vitiligo were selected for further review to calculate relative risks compared to the general population. Results: The annual prevalence of vitiligo determined by hospital-visitingrate in Korea was 0.12% to 0.13% over a three year period. In sync with other previous epidemiological studies, there was bimodal distribution among the age groups and no difference between genders. Also, vitiligo in Korean population was associated with various autoimmune/non-autoimmune diseases such as thyroiditis, atopic dermatitis, and psoriasis. Conclusion: This study was by far the most comprehensivereview on prevalence of vitiligo using a data of total population in Korea. The prevalence is within a range of those reported in previous literatures, and increasedrisk of comorbidities such as thyroid diseases and psoriasis in vitiligo might aid clinicians in the initial work up of vitiligo patients and concurrent follow ups.
참고문헌 (27)
- Sheth VM, "Comorbidities associated with vitiligo: a ten-year retrospective study", Dermatology, 227, pp.311~315 (2013)
- Taïeb A, "The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force", Pigment Cell Res, 20, pp.27~35 (2007)
- Shah H, "Clinical and sociodemographic study of vitiligo", Indian J Dermatol Venereol Leprol, 74, pp.701~ (2008)
- Krüger C, "A review of the worldwide prevalence of vitiligo in children", adolescents and adults, 2012, pp.51, 1206~1212
- Park SY, "A clinical study of 217 cases of vitiligo", Korean J Dermatol, 19, pp.145~152 (1981)
- Taïeb A, "Vitiligo", pp.13~24 (2010), Springer
- Song YJ., "The South Korean Health Care System", JMAJ, 52, pp.206~209 (2009)
- Lee YK, "Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry", Osteoporos Int, 24, pp.707~711 (2013)
- Park SJ, "Five year nationwide incidence of rhegmatogenous retinal detachment requiring surgery in Korea", PLoS One, 8, pp.e80174~ (2013)
- Lee YK, "Mortality after vertebral fracture in Korea: analysis of the National Claim Registry", Osteoporos Int, 23, pp.1859~1865 (2012)
- "Summary of Census Population"[URL]
- Furue M, "Prevalence of dermatological disorders in Japan: a nationwide, cross-sectional, seasonal, multicenter, hospital-based study", J Dermatol, 38, pp.310~320 (2011)
- Lu T, "Vitiligo prevalence study in Shaanxi Province, China", Int J Dermatol, 46, pp.47~51 (2007)
- Zhao B, "Clinical Dermatology" (2001), Jiangsu Scientific Pres
- Xu YY, "An epidemiological survey for four skin diseases in Anhui", Chin J Dermatol, 35, pp.406~407 (2002)
- Hann SK, "A Monograph on the Basic and Clinical Science" (2000), Blackwell Science Ltd.
- Yu HJ, "Clinical study of vitiligo", Korean J Dermatol, 36, pp.1037~1042 (1998)
- Narita T, "Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families", Allergol Int, 60, pp.505~508 (2011)
- Silverberg JI, "Association between vitiligo and atopic disorders: a pilot study", JAMA Dermatol, 149, pp.983~986 (2013)
- Sawchuk M, "The coexistence of psoriasis and vitiligo: a review", J Cutan Med Surg, 16, pp.300~305 (2012)
- 윤재일, "한국인의 건선", 대한피부과학회지, 50(5), pp.387~402 (2012), 대한피부과학회[DOI]
- Tsai TF, "Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan", J Dermatol Sci, 63, pp.40~46 (2011)
- Zhu KJ, "Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo", PLoS One, 6, pp.e23089~ (2011)
- Bassiouny DA, "Role of interleukin-17 in the pathogenesis of vitiligo", Clin Exp Dermatol, 36, pp.292~297 (2011)
- Basak PY, "The role of helper and regulatory T cells in the pathogenesis of vitiligo", J Am Acad Dermatol, 60, pp.256~260 (2009)
- Jin Y, "NALP1 in vitiligo-associated multiple autoimmune disease", N Engl J Med, 356, pp.1216~1225 (2007)
- Spritz RA, "Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease", Thyroid, 20, pp.745~754 (2010)